#ONCOnews #OncoAlert #OncEd #LungCancer #Phase3Data #OncologyNews #ESMO2025

Scotland approves new treatment option for multiple myeloma patients - PharmaTimes Blenrep combination offers improved survival for those ineligible for lenalidomide

#Haematology #Oncology #Scotland #NHSScotland #multiplemyeloma #GSK #Blenrep #belantamabmafodotin #Blenrepcombination #lenalidomide #ScottishMedicinesConsortium #SMC #bortezomibanddexamethasone #BVd #SMCrecommendation #phase3data #DREAMM7study #progressionfreesurvival
zurl.co/ydmDa